Last updated on February 2020

A Phase III Randomized Blind Double Dummy Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

Brief description of study

The aim of the THEIA study is to determine if Alteplase administrated within 4.5 hours improve visual deficit due to acute CRAO with a good safety profile.

Clinical Study Identifier: NCT03197194

Find a site near you

Start Over

CH d'Arras

Arras, France
  Connect »